Back to search results

SPARK-CGM Implementation for Diabetes Mellitus

This study, called SPARK-CGM, aims to make continuous glucose monitoring (CGM) more available to people with diabetes who receive care at Montefiore primary care clinics. CGM is a technology that helps you track your blood sugar levels in real-time, which can lead to better blood sugar control and quality of life. Even though CGM is very helpful, it's not widely used in primary care. This study will test a new approach to help clinics prescribe CGM more often and easily. The study will look at how quickly primary care providers start prescribing CGM after the SPARK-CGM program is put into place. You may be eligible if you are an adult patient at a Montefiore primary care site.

Study design
This interventional study plans to enroll 20,000 participants. It compares a streamlined CGM prescribing workflow to standard care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, time to first CGM prescription, is measured for up to 18 months after the intervention begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07548372

SPARK-CGM Implementation

Recruiting
NAAges 18+InterventionalHealth services
Montefiore Medical Center
~20,000 participants
Updated 2026-06-23 on ClinicalTrials.gov
What's tested:Enhanced CGM InterventionsStandard of Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time to first CGM prescription by primary care provider
Measured over Up to 18 months following initiation of intervention

Conditions

Diabetes Mellitus

Explore related trials

Diabetes Mellitus

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Jovan Milosavljevic, MD · PRINCIPAL_INVESTIGATOR · Montefiore Medical Center

Who to contact

Rosina Antwi
[email protected]
646-515-8399
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All adult Montefiore primary care sites
Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff
Age 18 years or older
Receive primary care at participating sites
Diagnosis of any diabetes mellitus
Treated with insulin therapy

What this trial measures

  • Time to first CGM prescription by primary care providerUp to 18 months following initiation of intervention

    Time to first CGM prescription initiated by a primary care provider (PCP) will be defined as the date from a patient's first eligible primary care encounter during the study period to the date of the first CGM prescription, up to 18 months following intervention initiation, as recorded in the electronic health record. All CGM orders are captured in the EHR. Results will be summarized by study arm using descriptive statistics and analyzed using Cox proportional hazards models.